Steven Hodak, MD

  • Specialty: Endocrinology
  • Language: English
  • Phone: 212-481-1350

About Me

I’ve always gravitated toward medicine, even in high school, when I was fascinated by physiology, which is the study of how the body works. I chose to specialize in endocrinology because of my particular interest in the role of hormones—molecules that are made by glands and carry messages to organs about numerous body functions. One of the most important glands is the thyroid, which is a butterfly-shaped gland in the base of the neck that controls all the metabolic processes of the body.

My specialty is in diagnosing and treating people who have thyroid nodules and thyroid cancer. Though thyroid nodules are common, thyroid cancer is not. Knowing how to distinguish the small number of nodules that are cancerous from the much larger number that are benign is therefore very important.

I am a national expert in molecular thyroid diagnosis, which tests DNA and RNA in thyroid nodule cells to determine which nodules have a very low or high risk of containing thyroid cancer. These tests are done after fine needle aspiration biopsy, which is a nearly painless procedure used to obtain thyroid cells.

By looking at the cells under a microscope and using molecular diagnostic tests, we can determine whether thyroid surgery is absolutely necessary or observation—keeping an eye on the nodules—is more appropriate. Molecular diagnostics can also help us to identify the genetic makeup of thyroid cancer cells, ensuring the best possible match between treatment and the specific genes that make cancers grow.

My expertise in fine needle aspiration biopsy and advanced molecular genetic tests, many of which I helped to develop, has significantly improved our ability to diagnose and treat people who have thyroid cancer, especially when the cancer would otherwise be undetectable.

I work with an amazing multidisciplinary team of surgeons, pathologists, radiologists, nuclear medicine physicians, and oncologists. Together, we provide world-class care for people who have problems that range from simple thyroid nodules to the most complex type of thyroid cancer.

My patients are my top priority, and I am dedicated to providing accessible and compassionate treatment to prevent the condition from diminishing your quality of life, both now and in the future.


Conditions and Treatments

thyroid nodule, thyroid cancer

Credentials

Positions
  • Professor, Department of Medicine
  • Assoc Dir of Clinical Aff, Div of Endocrinology
  • Director, Medicine Faculty Group Practice
  • Director, Glycemic Control at Tisch Hos
  • Chief, Endocrinology at Tisch Hospital
Board Certifications
  • American Board of Internal Medicine (Endocrinology, Diabetes & Metabolism), 2005
  • American Board of Internal Medicine - Internal Medicine, 2004
Education and Training
  • Fellowship, Georgetown University Hospital, 2005
  • Residency, Georgetown University Hospital, Endocrinology & Metabolism, 2003
  • MD from Georgetown University, 1999
Departments

Locations and Appointments

71 Insurance Plans Accepted
  • Aetna HMO
  • Aetna Indemnity
  • Aetna Medicare
  • Aetna POS
  • Aetna PPO/EPO
  • Affinity
  • Affinity Exchange- Essential
  • Agewell
  • Alphacare
  • Cigna EPO/POS
  • Cigna PPO
  • ElderPlan
  • Empire Blue Cross Blue Shield EPO
  • Empire Blue Cross Blue Shield HMO
  • Empire Blue Cross Blue Shield HealthPlus
  • Empire Blue Cross Blue Shield HealthPlus Essential
  • Empire Blue Cross Blue Shield Indemnity
  • Empire Blue Cross Blue Shield MediBlue
  • Empire Blue Cross Blue Shield POS
  • Empire Blue Cross Blue Shield PPO
  • Empire Blue Cross Blue Shield Pathways, Enhanced
  • Fidelis Child Health
  • Fidelis Essential
  • Fidelis Exchange
  • Fidelis Family Health
  • Fidelis Medicaid
  • Fidelis Medicare
  • GHI CBP
  • HIP Access I
  • HIP Access II
  • HIP Child Health
  • HIP EPO/PPO
  • HIP Essential
  • HIP Family Health
  • HIP HMO
  • HIP Medicaid
  • HIP Medicare
  • HIP POS
  • Healthfirst
  • Healthfirst Essential
  • Humana Medicare
  • Local 1199 PPO
  • MagnaCare PPO
  • Medicare
  • MetroPlus Child Health
  • MetroPlus Essential
  • MetroPlus Exchange Plans
  • MetroPlus Family Health
  • MetroPlus Medicaid
  • MetroPlus Medicare
  • MultiPlan/PHCS PPO
  • NY Medicaid
  • NYS Empire Plan
  • Oscar
  • Oxford Freedom
  • Oxford Liberty
  • Oxford Medicare
  • Tricare
  • UnitedHealthcare Community & State Plan
  • UnitedHealthcare Core and Charter
  • UnitedHealthcare EPO
  • UnitedHealthcare HMO
  • UnitedHealthcare Medicare
  • UnitedHealthcare POS
  • UnitedHealthcare PPO
  • UnitedHealthcare Top Tier
  • Visiting Nurse Service (VNS) Medicare
  • WellCare Child Health
  • WellCare Family Health
  • WellCare Medicaid
  • WellCare Medicare
*Insurance listed above may not be accepted at all office locations. Please confirm prior to each visit. The information presented here may not be complete or may have been changed.
NYU Diabetes & Endocrine Associates

530 1st Avenue, Suite 5F
New York, NY 10016

Welcome back!

As a returning patient for this doctor, please schedule an appointment using your MyChart at NYU Langone account.

Learn more about MyChart at NYU Langone.

“My research focuses on the creation of genetic tests to better diagnose and treat people with thyroid cancer.”

Steven Hodak, MD Endocrinologist

My Research

Dr. Hodaks clinical research focuses on the use of molecular genetic tools to improve diagnostic yield of thyroid nodule fine-needle aspiration biopsies. These novel techniques allow better risk stratification of thyroid cancer patients and identify those thyroid nodules most likely to be benign so they may be followed conservatively without surgery. These important molecular tools spare many patients from unnecessary thyroid surgery, and minimize associated human and economic costs. Dr. Hodak has co-authored numerous peer-reviewed articles in this field, performs hundreds of thyroid fine-needle biopsies annually, and has developed patient databases and tissue biorepositories required for successful translational research. Through his work, Dr. Hodak has become nationally recognized in the field of thyroid cancer and molecular diagnostics, serving on professional committees and speaking widely. He has been a past thyroid section chair for the Endocrine Society's Clinical Endocrinology Update Steering Committee and continues to serve on the American Thyroid Association Clinical Affairs Committee where he authored that groups position statement regarding clinical use of molecular genetic testing for thyroid cancer diagnosis. He is a Best Doctor in New York and has been recognized annually as one of Americas Best Doctors for over a decade.

Publications

  • Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): A changing paradigm in thyroid surgical pathology and implications for thyroid cytopathology

    Baloch, Zubair W; Seethala, Raja R; Faquin, William C; Papotti, Mauro G; Basolo, Fulvio; Fadda, Guido; Randolph, Gregory W; Hodak, Steven P; Nikiforov, Yuri E; Mandel, Susan J
    Cancer cytopathology. 2016 May 20. ?-?

  • Changing the Cancer Diagnosis - the Case of Follicular Variant of Papillary Thyroid Cancer Primum, Non Nocere and NIFTP

    Hodak, Steven; Tuttle, R Michael Md; Maytal, Guy; Nikiforov, Yuri E; Randolph, Gregory
    Thyroid. 2016 Jun 10. 26 (7): 869-871

  • Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors

    Nikiforov, Yuri E; Seethala, Raja R; Tallini, Giovanni; Baloch, Zubair W; Basolo, Fulvio; Thompson, Lester D R; Barletta, Justine A; Wenig, Bruce M; Al Ghuzlan, Abir; Kakudo, Kennichi; Giordano, Thomas J; Alves, Venancio A; Khanafshar, Elham; Asa, Sylvia L; El-Naggar, Adel K; Gooding, William E; Hodak, Steven P; Lloyd, Ricardo V; Maytal, Guy; Mete, Ozgur; Nikiforova, Marina N; Nose, Vania; Papotti, Mauro; Poller, David N; Sadow, Peter M; Tischler, Arthur S; Tuttle, R Michael; Wall, Kathryn B; LiVolsi, Virginia A; Randolph, Gregory W; Ghossein, Ronald A
    JAMA oncology. 2016 Apr 14. ?-?

Read All Publications (41)